Project Number 5R44AG066378-03 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Novel Dopaminergic Stimulant Prodrug for the Treatment of Apathy in AD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 10. Clinical Therapy Development for the Neuropsychiatric Symptoms of Dementia a. Pharmacological Researcher and Organization Principal Investigator PATIL, SANDEEP Principal Investigator First Name SANDEEP Principal Investigator Last Name PATIL Awardee Organization PRAXIS BIORESEARCH, LLC Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $957,571 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
